A nutritional or dietary supplement composition useful for formulating meal replacements, particularly beverage-based meal replacements. The composition is absorbed well in patients with compromised gastrointestinal absorption status, such as those having undergone bariatric surgery, other gastrointestinal surgery, those undergoing chemotherapy, and those with other gastrointestinal absorption disorders. Moreover, the compositions are nutritious foods for healthy people. Lastly, the compositions are useful for people with insulin disorders, difficulty maintaining healthy body weight, or inflammation-related disorders. Related methods are also provided.

A nutritional or dietary supplement composition useful for formulating meal replacements, particularly beverage-based meal replacements. The composition is absorbed well in patients with compromised gastrointestinal absorption status, such as those having undergone bariatric surgery, other gastrointestinal surgery, those undergoing chemotherapy, and those with other gastrointestinal absorption disorders. Moreover, the compositions are nutritious foods for healthy people. Lastly, the compositions are useful for people with insulin disorders, difficulty maintaining healthy body weight, or inflammation-related disorders. Related methods are also provided.

A nutraceutical formulation used to unblock receptors is disclosed herein. The nutraceutical formulation used to therapeutically treat humans includes arachidonic acid, docosahexaenoic acid (DHA), echinacea, kaempferol, coffee fruit, and probiotics.

A nutraceutical formulation used to unblock receptors is disclosed herein. The nutraceutical formulation used to therapeutically treat humans includes arachidonic acid, docosahexaenoic acid (DHA), echinacea, kaempferol, coffee fruit, and probiotics.

The invention relates to the use of a composition comprising at least one mixture of molecules obtained from Vitis vinifera and Vaccinium angustifolium, said mixture comprising: at least 1% of catechins and/or epicatechins, the percentage being given by weight relative to the total weight of the mixture, at least 5 ppm (parts per million in the mixture) of ferulic acid, and at least 200 ppm of resveratrol,
as a single dose in a healthy human being or animal to improve or maintain cognitive functions.

The invention relates to the use of a composition comprising at least one mixture of molecules obtained from Vitis vinifera and Vaccinium angustifolium, said mixture comprising: at least 1% of catechins and/or epicatechins, the percentage being given by weight relative to the total weight of the mixture, at least 5 ppm (parts per million in the mixture) of ferulic acid, and at least 200 ppm of resveratrol,
as a single dose in a healthy human being or animal to improve or maintain cognitive functions.

The oral supplements of the present invention utilize phenolic compounds in combination with creatine, choline, and trisodium citrate, wherein when taken together result in enhanced cellular permeation in comparison to cellular permeation in the absence of the other compounds of the combination leading to improved brain and/or physical functioning.

The oral supplements of the present invention utilize phenolic compounds in combination with creatine, choline, and trisodium citrate, wherein when taken together result in enhanced cellular permeation in comparison to cellular permeation in the absence of the other compounds of the combination leading to improved brain and/or physical functioning.

Various embodiments of the invention relate to compositions comprising vitamins, minerals and trace elements, antioxidants, amino acids, probiotics, and other components and methods for using such compositions to treat or prevent diseases associated with oxidative stress, including cardiovascular disease.

Various embodiments of the invention relate to compositions comprising vitamins, minerals and trace elements, antioxidants, amino acids, probiotics, and other components and methods for using such compositions to treat or prevent diseases associated with oxidative stress, including cardiovascular disease.